Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
Highlights
Infant formula company Bobbie raises $70M in Series C funding and acquires Nature’s One.
Sonio raises $14M in Series A funding for its AI-based prenatal screening and diagnostics platform.
Belgium-based menstrual health supplement startup Guud adds $1.7M in seed funding to invest in growth.
Researchers secure £1.5M for their ‘Fastball’ test to detect Alzheimer’s earlier.
Gynecological health startup Daye launches its new virtual period pain clinic.
FDA approvesMedicines360‘s LILETTA for the treatment of heavy menstrual bleeding.
Pharma company Fresenius Kabilaunches generic fertility treatment.
Freya Biosciences‘ FB101 shows promise in the treatment of vaginal dysbiosis.
Proov‘s Confirm PdG Ovulation test becomes first third party women’s health test available through Questhealth.com.
Indonesia: SoftBank-backed digital health platform Alodokteracquires pregnancy app Diary Bunda.
L’Oreal reveals new study on the impact of hormonal variations on women’s skin.
In the Know
Innovation Spotlight: Uterine Fibroids (Femtech Insider)
Pink Salt Ventures Calls for Investor-Side Reform to Address Gender Funding Gap in the UK (Femtech Insider)
Why Culturally Competent Care for Women of Color Matters (Commonwealth Fund)
Why Working with Incumbents Offers a Path to Success for Healthtech Startups (MedCityNews)
Women’s Health: Tackle the Research Funding Deficit (Nature)
AI may be key to solving the most neglected women’s health issues (National Geographic)
NHS at 75: Records from 1948 show changing women’s healthcare (BBC)
